您当前的位置：
首页 >
文章列表页 >
Clinical study of Quxie Capsule combined with fruquintinib in the treatment of metastatic colorectal cancer and prolonging third-line survival
Hematology and Oncology | 更新时间：2024-12-30

    • Clinical study of Quxie Capsule combined with fruquintinib in the treatment of metastatic colorectal cancer and prolonging third-line survival

    • “The latest research shows that the combination of Quxie Capsules and Fruquintinib can significantly prolong the overall survival and progression free survival of patients with metastatic colorectal cancer.”
    • Journal of Beijing University of Traditional Chinese Medicine   Vol. 47, Issue 12, Pages: 1759-1768(2024)

    • DOI：10.3969/j.issn.1006-2157.2024.12.016    

      CLC： R273

    • Received：21 August 2024，

      Published Online：29 November 2024，

      Published：30 December 2024

    移动端阅览

  • BIAN Jiangyu, HE Wenting, WANG Xueqian, et al. Clinical study of Quxie Capsule combined with fruquintinib in the treatment of metastatic colorectal cancer and prolonging third-line survival[J]. Journal of beijing university of traditional chinese medicine, 2024, 47(12): 1759-1768. DOI： 10.3969/j.issn.1006-2157.2024.12.016.

  •  
  •  

0

Views

4

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Efficacy and safety of Jianpi Bushen Jiedu formula combined with apatinib and S-1 in the treatment of metastatic colorectal cancer

Related Author

Yue CHEN
Haijun JIANG
Yuying XU
Lei WANG
Jiawei ZHAI
Tong ZHANG
Yufei YANG

Related Institution

Beijing University of Chinses Medicine
Department of Oncology, Central Hospital of Ankang City
Department of Oncology, Xiyuan Hospital, China Academy of Chinese Medical Sciences
0